Use of contrast media in emergency investigations: Risks and guidelines for their prevention;Utilisation des produits de contraste au cours des examens radiologiques réalisés en urgence: Risques et précautions à prendre

Reanimation

Volumn 12, Issue 7, 2003, Pages 510-518

  Lavigne, T ^a   Imhoff, O ^a   Roedlich, M N ^a   Meziani, F ^a   Castelain, V ^a   Schneider, F ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

Allergy; Contrast media; Emergency; Renal failure, acute

Indexed keywords

ACETYLCYSTEINE; IODINATED CONTRAST MEDIUM;

ALLERGY; DEATH; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; EMERGENCY TREATMENT; HUMAN; HYDRATION; INFUSION; KIDNEY DISEASE; KIDNEY FAILURE; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; SIDE EFFECT;

EID: 0344444745     PISSN: 16240693     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reaurg.2003.08.003     Document Type: Short Survey

References (59)

1. Lorusso V, Taroni P, Alvino S, Spinazzi A. Pharmacokinetics and safety of iomeprol in healthy volunteers and in patients with renal impairment or end-stage renal disease requiring hemodialysis. Invest Radiol 2001;36:309-16.
2. Recommandations pour l'emploi et le choix des différentes classes de produits de contraste iodés hydrosolubles lors des examens tomoden-sitométriques et urographiques - Conférence de consensus - Journées francophones de rRadiologie, Paris. Rev Im Med, 6. 1994. p. 183-4.
3. Greenberger PA. Contrast media reactions. J Allergy Clin Immunol 1984;74:600-5.
4. Kounis N, Zavras G. Histamine-induced coronary artery spasm: the concept of allergic angina. Br J Clin Pract 1991;45:121-8.
5. Webb JA, Stacul F, Thomsen HS, Morcos SK, Members of the contrast media safety committee of the European society of urogenital radiology. Late adverse reactions to intravascular iodinated contrast media. Eur Radiol 2003;13:181-4.
6. Munechika H, Hiramatsu Y, Kudo S, Sugimura K, Hamada C, Yamaguchi K, et al. A prospective survey of delayed adverse reactions to iohexol in urography and computed tomography. Eur Radiol 2003; 13:185-94.
7. Laroche D, Aimone-Gastin I, Dubois F, Huet H, Gerard P, Vergnaud MC, et al. Mechanisms of severe immediate reactions to iodinated contrast material. Radiology 1998;209:183-90.
8. Ginsburg R, Bristow MR, Kantrowitz N, Baim DS, Harrisson DC. Histamine provocation of clinical coronary artery spasm: implications concerning pathogenesis of variant angina pectoris. Am Heart J 1981; 102:809-22.
9. Sakata Y, Komamura K, Hirayama A, Nanto S, Kitakaze M, Hori M, et al. Elevation of the plasma histamine concentration in the coronary circulation in patients with variant angina. Am J Cardiol 1996;77:1121-6.
10. Hong SJ, Wong JT, Bloch KJ. Reactions to radiocontrast media. Allergy Asthma Proc 2002;23:347-51.
11. Monneret-Vautrin DA, Kanny G, Morisset M, Beaudouin E, Renaudin JM. Réactions anaphylactoïdes et cutanées tardives aux produits de contraste iodés: état actuel de la question - évolution des idées. Rev Med Interne 2001;22:969-77.
12. e congrès national d'anesthésie réanimation. Paris: Elsevier et Sfar; 1998. p. 277-97.
13. Lasser EC, Lyon SG, Berry CC. Reports on contrast media reactions: analysis of data from reports to the Food and Drug Adminstration. Radiology 1997;203:605-10.
14. Dawson P, Turner MW, Bradshaw A, Westaby S. Complement activation and generation of C3a anaphylatoxin by radiological contrast agents. Br J Radiol 1983;56:447-8.
15. Lalli AF. Urographic contrast media reactions and anxiety. Radiology 1974;112:267-71.
16. Shehadi WH. Contrast media adverse reactions: occurrence, recurrence and distribution patterns. Radiology 1982;143:11.
17. Lang DM, Alpern MB, Visintainer PF, Smith ST. Elevated risk of anaphylactoid reaction from radiographic contrast media is associated with both betablocker exposure and cardiovascular disorders. Arch Intern Med 1993;153:2033-40.
18. Barrett BJ, Parfrey PS. Prevention of nephrotoxicity induced by radiocontrast agents. N Engl J Med 1994;331:1449-50.
19. Rudnick MR, Berns JS, Cohen RM, Goldfarb S. Contrast-media associated nephrotoxicity. Semin Nephrol 1997;17:15-26.
20. Mc Culloug PA, Wolyn R, Rocher LL, Levin RN, O'Neil WW. Acute renal failure after coronary interventions: incidence, risk factors, and relationship mortality. Am J Med 1997;103:368-75.
21. Rudnick MR, Berns JS, Cohen RM, Goldfarb S. Nephrotoxic risks of renal angiography: contrast-media associated nephrotoxicity and athero-embolism a critical review. Am J Kidney Dis 1994;24:713-27.
22. Hizoh I, Sträter J, Schick CS, Kübler W, Haller C. Radiocontrast-induced DNA fragmentation of renal tubular cells in vitro: role of hypertonicity. Nephrol Dial Transplant 1998;13:911-8.
23. Schick CS, Haller C. Comparative cytotoxicity of ionic and non-ionic radiocontrast agents on MDCK cell monolayers in vitro. Nephrol Dial Transplant 1999;14:342-7.
24. Qi Z, Hao C-M, Langenbach RI, Breyer RM, Redha R, Morrow JD, et al. Opposite effects of cyclo-oxygenase-1 and -2 activity on the pressor response to angiotensin II. J Clin Invest 2002;110:61-9.
25. Kurnik BRC, Allgren RL, Genter FC, Solomon RJ, Bates ER, Weisberg LS. Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 1998;31: 674-80.
26. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997;103:368-75.
27. Freeman RV, O'Donnell M, Share D, Meengs WL, Kline-Rogers E, Clark VL, et al. Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol 2002;90:1068-73.
28. Wolf GL, Mulry CS, Kilzer K, Laski PA. New angiographic agents with less fibrillation propensity. Invest Radiol 1981;4:320-3.
29. Morris TW. The importance of sodium concentration on the incidence of fibrillation during coronary arteriography in dogs. Invest Radiol 1988;23:S137-9.
30. Nyman U, Almen T, Landtman M. Effect of contrast media on femoral blood flow. Comparison between non-ionic and ionic monomeric and mono-acidic dimeric contrast media in the dog. Acta Radiol Suppl 1980;362:41-8.
31. Hirschfeld JW, Laskey W, Martin JL, Groh WC, Untereker W, Wolf GL. Hemodynamic changes induced by cardiac angiography with ioxaglate: comparison with diatrizoate. J Am Coll Cardiol 1983; 2:954-7.
32. Dawson P, Harrison MJ, Weisblatt E. Effect of contrast media on red cell filtrability and morphology. Br J Radiol 1983;56:707-10.
33. Raininko R, Ylinen SL. Effect of ionic and non-ionic contrast media on aggregation of red blood cells in vitro. A preliminary report. Acta Radiol 1987;28:87-92.
34. Fareed J, Walenga JM, Saravia GE, Moncada RM. Thrombogenic potential of non ionic contrast media? Radiology 1990;174:321-5.
35. Ing JJ, Smith DC, Bull BS. Differing mechanisms of clotting inhibition by ionic and non-ionic contrast agents. Radiology 1989;172: 345-8.
36. Grines CL, Schreiber TL, Savas V, Jones DE, Zidar FJ, Gangadharan V, et al. A randomized trial of low osmolar ionic vs non-ionic contrast media in patients with myocardial infarction or unstable angina undergoing percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1996;27:1381-6.
37. Murphy KP, Szopinski KT, Cohan RH, Mermillod B, Ellis JH. Occurrence of adverse reactions to gadolinium based contrast material and management of patients at increased risk: a survey of the American Society of Neuroradiology Fellowship directors. Acad Radiol 1999;6: 656-64.
38. Recommandations pour l'emploi et le choix des différentes classes de produits de contraste iodés hydrosolubles lors des examens tomoden-sitométriques et urographiques - Conférence de consensus - Journées francophones de radiologie, Paris. Rev Im Med, 6. 1994. p. 183-4.
39. Morcos SK, Thomsen HS, Webb JAW. Contrast Media Safety Committee of the European Society of Urogenital Radiology. Prevention of generalized reactions to contrast media: a consensus report and guidelines. Eur Radiol 2001;11:1720-8.
40. Thomsen HS, Morcos SK. Contrast Media Safety Committee of the European Society of Urogenital Radiology. Prevention of generalized reaction to contrast media. Acad Radiol 2002;9(2):S433-5.
41. Greenberger PA, Patterson R. The prevention of immediate generalized reactions to radiocontrast media in high-risk patients. J Allergy Clin Immunol 1991;87:867-72.
42. Waybill MM, Waybill PN. Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention. J Vasc Interv Radiol 2001;12:3-9.
43. Eisenberg RL, Bank WO, Hedgock MW. Renal failure after major angiography can be avoid with hydratation. Am J Roentgenol 1981; 136:859-61.
44. Davidson CJ, Hlatky M, Morris KG, Pieper K, Skelton TN, Schwab SJ, et al. Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial. Ann Intern Med 1989;110:119-24.
45. Mueller C, Buerkle G, Buettner HJ, Petersen J, Perruchoud AP, Eriksson U, et al. Prevention of contrast media-associated nephropathy. Arch Intern Med 2002;162:329-36.
46. Taylor AJ, Hotchkiss D, Morse RW, McCabe J. Prepared: Preparation for Angiography in Renal Dysfunction: a randomized trial of inpatient vs outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction. Chest 1998;114:1570-4.
47. Solomon R, Werner C, Mann D, D'Hélia J, Silva P. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994;331:1416-20.
48. Stevens MA, McCullough PA, Tobin KJ, Speck JP, Westveer DC, Guido-Allen DA, et al. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the Prince study. J Am Coll Cardiol 1999;33:403-11.
49. Wang A, Bashore T, Holcslaw T, Freed M, Shusterman N, Schwab SJ. Randomized prospective double blind multicenter trial of an endothelin receptor antagonist in the prevention of contrast nephrotoxicity. J Am Soc Nephrol 1998;9:137 A.
50. Brinker JA, Sketch M, Koch JA, Kernink P. PGE 1 prophylaxis against contrast-induced nephropathy in patients with pre-existent renal compromise: results of a randomized, controlled pilot trial. Circulation 1998;98:1-707.
51. Birck R, Krzossok S, Markowetz F, Schnulle P, Van Der Woude FJ, Braun C. Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet 2003;362:598-603.
52. Durham JD, Caputo C, Dokko J, Zaharakis T, Phalavan M, Keltz J, et al. A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography. Kidney Int 2002;62:2202-7.
53. Weisberg LS, Kurnik PB, Kurnik BRC. Dopamine and renal blood flow in radiocontrast-induced nephropathy in humans. Renal Failure 1993;15:61-8.
54. Abizaid AS, Clark CE, Minz GS, Dosa S, Popma JJ, Pichard AD, et al. Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with pre-existing renal insufficiency. Am J Cardiol 1999;83:260-3.
55. Tumlin J, Mathur V. Prophylactic efficacy of fenoldopam in radiocontrast nephropathy: a randomized, double-blind, placebo-controlled trial. J Vasc Interv Radiol 2000;11:175.
56. Barkis GL, Lass NA, Glock D. Renal hemodynamics in radiocontrast medium-induced renal dysfunction: a role for dopamine-1 receptors. Kidney Int 1999;56:206-10.
57. Barrett BJ, Carlisle EJ. Meta-analysis of the relative nephrotoxicity of high-and low-osmolality iodinated contrast media. Radiology 1993; 188:171-8.
58. Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ. Nephrotoxicity in high-risk patients study of iso-osmolar and low-osmolar non-ionic contrast media study investigators. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003;348:491-9.
59. Vogt B, Ferrari P, Schonholzer C, Marti HP, Mohaupt M, Wiederkehr M, et al. Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med 2001;111:692-8.